Sareum Holdings plc (LON:SAR – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 33.71 ($0.44) and traded as low as GBX 31.11 ($0.40). Sareum shares last traded at GBX 32 ($0.41), with a volume of 146,816 shares trading hands.
Sareum Stock Up 1.6 %
The firm’s 50-day moving average is GBX 37.02 and its 200-day moving average is GBX 33.52. The company has a market cap of £34.54 million, a PE ratio of -533.33 and a beta of -1.03.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Read More
- Five stocks we like better than Sareum
- What is a Special Dividend?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Business Services Stocks Investing
- Why Call Options Volume for These 2 Stocks Spiked Together
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
